UY30236A1 - INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE - Google Patents

INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE

Info

Publication number
UY30236A1
UY30236A1 UY30236A UY30236A UY30236A1 UY 30236 A1 UY30236 A1 UY 30236A1 UY 30236 A UY30236 A UY 30236A UY 30236 A UY30236 A UY 30236A UY 30236 A1 UY30236 A1 UY 30236A1
Authority
UY
Uruguay
Prior art keywords
adenylate
cycling
inhibitors
soluble
medicines
Prior art date
Application number
UY30236A
Other languages
Spanish (es)
Inventor
Bernd Menzenbach
Bernd Buchmann
Martin Fritsch
Dirk Kosemund
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of UY30236A1 publication Critical patent/UY30236A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Compuestos de la formula general I, su preparacion y su uso como medicamentos.Compounds of the general formula I, their preparation and their use as medicines.

UY30236A 2006-03-23 2007-03-23 INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE UY30236A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006014320A DE102006014320B4 (en) 2006-03-23 2006-03-23 Inhibitors of the soluble adenylate class

Publications (1)

Publication Number Publication Date
UY30236A1 true UY30236A1 (en) 2007-10-31

Family

ID=38229991

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30236A UY30236A1 (en) 2006-03-23 2007-03-23 INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE

Country Status (12)

Country Link
EP (1) EP2001847A2 (en)
JP (1) JP2009531319A (en)
KR (1) KR20090007351A (en)
CN (1) CN101448789A (en)
AR (1) AR063661A1 (en)
CA (1) CA2646650A1 (en)
DE (1) DE102006014320B4 (en)
DO (1) DOP2007000059A (en)
PE (1) PE20080012A1 (en)
TW (1) TW200815347A (en)
UY (1) UY30236A1 (en)
WO (1) WO2007107385A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2036906A1 (en) * 2007-09-05 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Azaindoles as inhibitors of soluble adenylate cyclase
CN108096244B (en) * 2018-01-25 2020-11-24 昆明医科大学 Application of 1-hydrogen-2-indolone-3-benzyl/substituted benzyl-3-formate compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7442805B2 (en) * 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7569604B2 (en) * 2004-06-22 2009-08-04 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives for modulation of calcium channels
DE102004047272A1 (en) * 2004-09-24 2006-04-06 Schering Ag Inhibitors of soluble adenylate cyclase

Also Published As

Publication number Publication date
EP2001847A2 (en) 2008-12-17
DE102006014320B4 (en) 2009-01-22
PE20080012A1 (en) 2008-04-03
DE102006014320A1 (en) 2007-09-27
WO2007107385A2 (en) 2007-09-27
WO2007107385A3 (en) 2007-11-29
DOP2007000059A (en) 2007-09-30
JP2009531319A (en) 2009-09-03
CN101448789A (en) 2009-06-03
TW200815347A (en) 2008-04-01
KR20090007351A (en) 2009-01-16
AR063661A1 (en) 2009-02-11
CA2646650A1 (en) 2007-09-27

Similar Documents

Publication Publication Date Title
CO6321282A2 (en) PIPERIDINYLINDOL DERIVATIVES AS INHIBITORS OF ALDOSTERONA SINTASA
EA201170772A1 (en) ORGANIC COMPOUNDS
NO20090295L (en) Substituted heteroaryl derivatives
CL2007002316A1 (en) COMPOUNDS DERIVED FROM PYRIMIDINE, PI3K INHIBITORS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN PROLIFERATIVE DISEASES AS CANCER.
EA201070519A1 (en) TROPAN CONNECTIONS
NO20083630L (en) New pyridine derivatives
UY31673A1 (en) "UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME-211"
ECSP088904A (en) ARILIMIDAZOLONAS AND ARILTRIAZOLONAS REPLACED AS INHIBITORS OF VASOPRESINE RECEPTORS
CR20120634A (en) DERIVATIVES OF HETEROARIL IMIDAZOLONA AS JAK INHIBITORS
ATE553104T1 (en) SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDE AS POTENT PARP INHIBITORS
EA201170832A1 (en) PURINE CONNECTIONS
ATE445593T1 (en) ACETYLENE DERIVATIVES
GT200800251A (en) SIPROCICLIC NITRILS AS PROTEASA INHIBITORS
PA8657801A1 (en) TRICYCLE AMINALCOHOLES, PROCEDURES FOR THEIR PREPARATION
EA201070327A1 (en) CATECHOLAMINE DERIVATIVES AND THEIR DEVICES
EA201000614A1 (en) PURIN DERIVATIVES AS LIGANDS OF THE Adenosine Receptor A
EA201071224A1 (en) LIMK2 INHIBITORS, COMPOSITIONS CONTAINING THEM, AND METHODS OF THEIR USE
UY28917A1 (en) DERIVATIVES OF TETRAHYDROISOQUINOLILSULFONAMIDS PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USE
EA200870148A1 (en) SULINDAC DERIVATIVES, THEIR APPLICATION AND RECEIVING
BRPI0911772A2 (en) compound, pharmaceutical composition, and use of the compound.
PA8646301A1 (en) INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE
EA201000069A1 (en) NEW HERBICIDES
UY30424A1 (en) DERIVATIVES OF QUINOLINA, ITS PREPARATION, ITS USE AND MEDICINES THAT UNDERSTAND THE SAME.
UY30235A1 (en) INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE
NO20091386L (en) Fenyloksyanilinderivater

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170606